Cargando…
Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model
BACKGROUND: Fuzheng Yiliu decoction (FZYLD), a Chinese formula consisting of four herbs, can be clinically used as an adjuvant therapy after surgery or palliative treatment for advanced liver cancer. METHODS: This study identified the endogenous and exogenous metabolites of FZYLD in rat serum to cha...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492441/ https://www.ncbi.nlm.nih.gov/pubmed/36160035 http://dx.doi.org/10.2147/CMAR.S377621 |
_version_ | 1784793482321199104 |
---|---|
author | Zhang, Hongcheng Dai, Qiwen Zeng, Maogui Liu, Yingying Du, Jian Pang, Wensheng Hu, Juan Chen, Liwu |
author_facet | Zhang, Hongcheng Dai, Qiwen Zeng, Maogui Liu, Yingying Du, Jian Pang, Wensheng Hu, Juan Chen, Liwu |
author_sort | Zhang, Hongcheng |
collection | PubMed |
description | BACKGROUND: Fuzheng Yiliu decoction (FZYLD), a Chinese formula consisting of four herbs, can be clinically used as an adjuvant therapy after surgery or palliative treatment for advanced liver cancer. METHODS: This study identified the endogenous and exogenous metabolites of FZYLD in rat serum to characterize the underlying mechanism of its antitumor activity, as well as relieving cancer-related weakness. An orthotopic transplantation rat model of HepG2 cells was established and administered with FZYLD by gastric perfusion for 14 days. Cardiopulmonary function and tail suspension test were used to evaluate the bodily weakness of hepatocellular carcinoma (HCC) rats. Tumor weight and size were measured to calculate inhibition ratios. Serum of different concentrations of FZYLD was used to culture the 2-[N-(7-nitrobenz-2-oxa-1, 3-diaxol-4-yl) amino]-2-deoxyglucose-labeled HepG2 cells. IC(50) value was measured using MTT assay. Endogenous and exogenous metabolites in rat serum were detected using nuclear magnetic resonance or LC-MS/MS spectroscopy. RESULTS: FZYLD improved cardiopulmonary function, decreased immobility time in tail suspension test, and yielded tumor inhibition ratios of up to 27%. Serum endogenous markers, such as lipoproteins (high- and low-density lipoproteins), glucose, and valine, and lactic acid metabolic disturbance were recovered, to some extent, in HCC rats. Exogenous metabolites, diosgenin, apigenin-7-O-acetyl-β-D-glucoside, calycosin-7-glucoside, calycosin, ganoderic-acid-A, formononetin, and methylnissolin, became detectable in the blood. FZYLD-containing serum substantially inhibited the proliferation of HepG2-cells. IC(50) value was found to be 24.31%. Further, we confirmed that FZYLD could revert energy and lipid metabolism disorders and that its constituents could be bioactive components that induce apoptosis in cancer cells. CONCLUSION: The present study explained the mechanism of the effect of FZYLD on body empty, fatigue, and low immunity in patients with cancer, offering an efficient way for research of natural compounds in traditional Chinese medicine. |
format | Online Article Text |
id | pubmed-9492441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-94924412022-09-22 Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model Zhang, Hongcheng Dai, Qiwen Zeng, Maogui Liu, Yingying Du, Jian Pang, Wensheng Hu, Juan Chen, Liwu Cancer Manag Res Original Research BACKGROUND: Fuzheng Yiliu decoction (FZYLD), a Chinese formula consisting of four herbs, can be clinically used as an adjuvant therapy after surgery or palliative treatment for advanced liver cancer. METHODS: This study identified the endogenous and exogenous metabolites of FZYLD in rat serum to characterize the underlying mechanism of its antitumor activity, as well as relieving cancer-related weakness. An orthotopic transplantation rat model of HepG2 cells was established and administered with FZYLD by gastric perfusion for 14 days. Cardiopulmonary function and tail suspension test were used to evaluate the bodily weakness of hepatocellular carcinoma (HCC) rats. Tumor weight and size were measured to calculate inhibition ratios. Serum of different concentrations of FZYLD was used to culture the 2-[N-(7-nitrobenz-2-oxa-1, 3-diaxol-4-yl) amino]-2-deoxyglucose-labeled HepG2 cells. IC(50) value was measured using MTT assay. Endogenous and exogenous metabolites in rat serum were detected using nuclear magnetic resonance or LC-MS/MS spectroscopy. RESULTS: FZYLD improved cardiopulmonary function, decreased immobility time in tail suspension test, and yielded tumor inhibition ratios of up to 27%. Serum endogenous markers, such as lipoproteins (high- and low-density lipoproteins), glucose, and valine, and lactic acid metabolic disturbance were recovered, to some extent, in HCC rats. Exogenous metabolites, diosgenin, apigenin-7-O-acetyl-β-D-glucoside, calycosin-7-glucoside, calycosin, ganoderic-acid-A, formononetin, and methylnissolin, became detectable in the blood. FZYLD-containing serum substantially inhibited the proliferation of HepG2-cells. IC(50) value was found to be 24.31%. Further, we confirmed that FZYLD could revert energy and lipid metabolism disorders and that its constituents could be bioactive components that induce apoptosis in cancer cells. CONCLUSION: The present study explained the mechanism of the effect of FZYLD on body empty, fatigue, and low immunity in patients with cancer, offering an efficient way for research of natural compounds in traditional Chinese medicine. Dove 2022-09-17 /pmc/articles/PMC9492441/ /pubmed/36160035 http://dx.doi.org/10.2147/CMAR.S377621 Text en © 2022 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhang, Hongcheng Dai, Qiwen Zeng, Maogui Liu, Yingying Du, Jian Pang, Wensheng Hu, Juan Chen, Liwu Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model |
title | Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model |
title_full | Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model |
title_fullStr | Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model |
title_full_unstemmed | Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model |
title_short | Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model |
title_sort | investigating the metabolic level of endogenous and exogenous substances on the intervention of traditional chinese medicine fuzheng yiliu decoction in a rat orthotopic liver cancer model |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492441/ https://www.ncbi.nlm.nih.gov/pubmed/36160035 http://dx.doi.org/10.2147/CMAR.S377621 |
work_keys_str_mv | AT zhanghongcheng investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel AT daiqiwen investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel AT zengmaogui investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel AT liuyingying investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel AT dujian investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel AT pangwensheng investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel AT hujuan investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel AT chenliwu investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel |